Abstract
Molecular Biomarkers in Peptic Ulcer Disease: Bridging Pathophysiology and Personalized Management. Peptic Ulcer Disease (PUD) presents a persistent global healthcare burden, marked by an epidemiological shift toward increasing Nonsteroidal Anti-inflammatory Drug (NSAID)-induced ulcers alongside Helicobacter pylori infection, emphasizing the need for precision diagnostic tools. PUD pathogenesis involves a breakdown of the mucosal defense barrier exacerbated by systemic (COX-1 inhibition) and direct cellular injury (oxidative stress). This review evaluates the utility of established and emerging molecular biomarkers in PUD management, focusing on diagnosis, prognosis, healing, and risk stratification. Key findings highlight that non-invasive tests (Urea Breath Test/Stool Antigen Test) reliably confirm active H. pylori presence, while Stool PCR provides critical predictive value by identifying antibiotic resistance mutations. The Pepsinogen I/II ratio is an indispensable prognostic biomarker, effectively stratifying patients for intensive endoscopic surveillance against atrophic gastritis and subsequent gastric cancer risk. Furthermore, markers of inflammation (e.g., high specificity of Interleukin-6) and oxidative stress (e.g., Malondialdehyde, Superoxide Dismutase) offer quantifiable molecular evidence of active mucosal damage and therapeutic response, moving assessment beyond endoscopic visualization. Although promising, advanced molecular assays, particularly MicroRNAs (miRNAs), require further standardization and validation to overcome limitations in cost and biological variability. In conclusion, the strategic application of these molecular biomarkers is essential for transitioning PUD management from empirical treatment to a mechanism-based, personalized approach, thereby reducing complication rates and improving long-term patient outcomes.
Keywords
Peptic Ulcer Disease (PUD), Biomarkers, Helicobacter pylori, NSAID-induced Ulcers, Pepsinogen I/II Ratio, Atrophic Gastritis, MicroRNAs (miRNAs), Oxidative Stress, Personalized Medicine
Introduction
I. Introduction: The Evolving Landscape of Peptic Ulcer Disease
A. Brief Overview of Peptic Ulcer Disease (PUD)
Peptic Ulcer Disease (PUD) is a prevalent gastrointestinal disorder defined by a mucosal discontinuity, characterized by breaks that extend through the entire thickness of the mucosa, penetrating into the submucosa or deeper layers of the stomach or duodenum.1 Pathophysiologically, PUD results from a critical breakdown in the delicate balance between aggressive factors (primarily hydrochloric acid and pepsin) and the stomach’s robust mucosal protective factors (mucus, bicarbonate, and adequate blood flow).2
Nishant Gite*
Maaz Aquil
Amol Jadhav
Girish Gore
10.5281/zenodo.17663366